Test Bank Abrams' Clinical Drug Therapy: Rationales for Nursing Practice 13th Edition by Geralyn Frandsen & Sandra Pennington Complete Chapter Guide 1-61 With Rationales| A+ PASS

Test Bank
Abrams' Clinical Drug Therapy: Rationales
for Nursing Practice
13th Edition
by Geralyn Frandsen & Sandra Pennington
Complete Chapter Guide 1-61 With Rationales| A+ PASS




1|P a g e
WS WS WS WS WS

, Table of Content SECT WS WS WS




ION 1 The Conceptual Framework of Pharmacology Chapter 1 T
WS WS WS WS WS WS WS WS WS




he Foundation of Pharmacology: Quality and Safety Chapter 2 Basic
WS WS WS WS WS WS WS WS WS WS




Concepts and Processes WS WS




Chapter 3 Medication Administration and the Nursing Process of Drug Therapy
WS WS WS WS WS WS WS WS WS WS




SECTION 2 Drug Therapy Throughout the Lifespan WS WS WS WS WS WS




Chapter 4 Pharmacology and the Care of Infants and Pediatric Patients Medication Administration in Pedi
WS WS WS WS WS WS WS WS WS WS WS WS WS WS




atrics

Chapter 5 Pharmacology and the Care of Adults and Geriatric Patients C
WS WS WS WS WS WS WS WS WS WS WS




hapter 6 Pharmacology and the Care of Pregnant or Lactating Woman Ch
WS WS WS WS WS WS WS WS WS WS WS




apter 7 Pharmacology and Women‘s Health
WS WS WS WS WS




Chapter 8 Pharmacology and Men‘s Health
WS WS WS WS WS




SECTION 3 Drugs Affecting the Hematopoietic and Immune Systems
WS WS WS WS WS WS WS WS




Chapter 9 Drug Therapy for Coagulation Disorders Ch
WS WS WS WS WS WS WS




apter 10 Drug Therapy for Dyslipidemia
WS WS WS WS WS




Chapter 11 Drug Therapy for Hematopoietic Disorders
WS WS WS WS WS WS WS




Chapter 12 Drug Therapy: Immunizations
WS WS WS WS




Chapter 13 Drug Therapy to Decrease Immunity Chap
WS WS WS WS WS WS WS




ter 14 Drug Therapy for the Treatment of Cancer
WS WS WS WS WS WS WS WS




SECTION 4 Drugs Affecting Inflammation and Infection
WS WS WS WS WS WS




Chapter 15 Inflammation, Infection, and the Use of Antimicrobial Agents
WS WS WS WS WS WS WS WS WS WS




Chapter 16 Drug Therapy to Decrease Pain, Fever, and Inflammation Ch
WS WS WS WS WS WS WS WS WS WS




apter 17 Drug Therapy With Corticosteroids
WS WS WS WS WS




Chapter 18 Drug Therapy With Beta-
WS WS WS WS WS




Lactam Antibacterial Agents Chapter 19 Drug Therapy With Aminoglyco
WS WS WS WS WS WS WS WS




sides and Fluoroquinolones
WS WS




Chapter 20 Drug Therapy With Tetracyclines, Sulfonamides, and Urinary Antiseptics Cha
WS WS WS WS WS WS WS WS WS WS




pter 21 Drug Therapy With Macrolides and Miscellaneous Anti-
WS WS WS WS WS WS WS WS




infective Agents Chapter 22 Drug Therapy for Tuberculosis and Mycobacterium avium Co
WS WS WS WS WS WS WS WS WS WS WS




mplex Disease Chapter 23 Drug Therapy for Viral Infections
WS WS WS WS WS WS WS WS




2|P a g e
WS WS WS WS WS

,Chapter 24 Drug Therapy for Fungal Infections Chapt
WS WS WS WS WS WS WS




er 25 Drug Therapy for Parasitic Infections
WS WS WS WS WS WS




SECTION 5 Drugs Affecting the Cardiovascular System WS WS WS WS WS WS




Chapter 26 Drug Therapy for Hypertension Cha
WS WS WS WS WS WS




pter 27 Drug Therapy for Dysrhythmias
WS WS WS WS WS




Chapter 28 Drug Therapy for Coronary Heart Disease
WS WS WS WS WS WS WS W




Chapter 29 Drug Therapy for Shock and Hypotension
S WS WS WS WS WS WS WS




WS Chapter 30 Drug Therapy for Heart Failure WS WS WS WS WS WS




SECTION 6 Drugs Affecting the Respiratory System WS WS WS WS WS WS




Chapter 31 Drug Therapy for Nasal Congestion and Cough
WS WS WS WS WS WS WS WS




Chapter 32 Drug Therapy to Decrease Histamine Effects and Allergic Response C
WS WS WS WS WS WS WS WS WS WS WS




hapter 33 Drug Therapy for Asthma and Bronchoconstriction
WS WS WS WS WS WS WS




SECTION 7 Drugs Affecting the Renal and Digestive Systems WS WS WS WS WS WS WS WS




Chapter 34 Drug Therapy for Fluid Volume Excess
WS WS WS WS WS WS WS




Chapter 35 Nutritional Support Products, Vitamins, and Mineral Supplements Cha
WS WS WS WS WS WS WS WS WS




pter 36 Drug Therapy for Weight Management
WS WS WS WS WS WS




Chapter 37 Drug Therapy for Peptic Ulcer Disease and Hyperacidity
WS WS WS WS WS WS WS WS WS WS




Chapter 38 Drug Therapy for Nausea and Vomiting
WS WS WS WS WS WS WS




Chapter 39 Drug Therapy for Constipation and Elimination Problems
WS WS WS WS WS WS WS WS WS




Chapter 40 Drug Therapy for Diarrhea WS WS WS WS WS




SECTION 8 Drugs Affecting the Endocrine System Ch WS WS WS WS WS WS WS




apter 41 Drug Therapy for Diabetes Mellitus
WS WS WS WS WS WS




Chapter 42 Drug Therapy for Hyperthyroidism and Hypothyroidism Chap
WS WS WS WS WS WS WS WS




ter 43 Drug Therapy for Pituitary and Hypothalamic Dysfunction Chapter
WS WS WS WS WS WS WS WS WS W




44 Drug Therapy to Regulate Calcium and Bone Metabolism Chapter 45
S WS WS WS WS WS WS WS WS WS WS WS




Drug Therapy for Addison‘s Disease and Cushing‘s Disease Section 9 Dr
WS WS WS WS WS WS WS WS WS WS




ugs Affecting the Autonomic and Central Nervous System
WS WS WS WS WS WS WS




Chapter 46 Physiology of the Autonomic and Central Nervous Systems and Indications for the Use of Dr
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




ug Therapy WS




3|P a g e
WS WS WS WS WS

, Chapter 47 Drug Therapy for Myasthenia Gravis, Alzheimer‘s Disease, and Urinary Retention
WS WS WS WS WS WS WS WS WS WS WS




Chapter 48 Drug Therapy for Parkinson‘s Disease, Urinary Spasticity, and Disorders Requiring
WS WS WS WS WS WS WS WS WS WS WS




Anticholinergic Drug Therapy WS WS




Chapter 49 Drug Therapy With Opioids WS WS WS WS WS




Chapter 50 Drug Therapy With Local Anesthetics
WS WS WS WS WS WS WS




Chapter 51 Drug Therapy With General Anesthetics
WS WS WS WS WS WS




Chapter 52 Drug Therapy for Migraines and Other Headaches
WS WS WS WS WS WS WS WS




Chapter 53 Drug Therapy for Seizure Disorders and Spasticit
WS WS WS WS WS WS WS WS WS




y Chapter 54 Drug Therapy for Anxiety and Insomnia
WS WS WS WS WS WS WS WS




Chapter 55 Drug Therapy for Depression and Mood Stabilization Cha
WS WS WS WS WS WS WS WS WS




pter 56 Drug Therapy for Psychotic Disorders
WS WS WS WS WS WS




Chapter 57 Drug Therapy for Attention Deficit Hyperactivity Disorder and Narcolepsy Ch
WS WS WS WS WS WS WS WS WS WS WS




apter 58 Drug Therapy for Substance Abuse Disorders
WS WS WS WS WS WS WS




Section 10 Drugs Affecting the Eye, Ear, and Skin
WS WS WS WS WS WS WS WS WS




Chapter 59 Drug Therapy for Disorders of the Eye Ch
WS WS WS WS WS WS WS WS WS




apter 60 Drug Therapy for Disorders of the Ear Chapt
WS WS WS WS WS WS WS WS WS




er 61 Drug Therapy for Disorders of the Skin
WS WS WS WS WS WS WS WS




Chapter 1 : The Foundation of Pharmacology: Quality and Safety :
WS WS WS WS WS WS WS WS WS WS




1. A woman diagnosed with obsessive–
WS WS WS WS




compulsive disorder has been prescribed oral paroxetine hydrochloride. What is the expected ef
WS WS WS WS WS WS WS WS WS WS WS WS




fect for this prescription?
WS WS WS




A. Curative effect on symptoms WS WS WS




B. Systemic effect on symptoms WS WS WS




C. Local effect on symptoms WS WS WS




D. Parenteral effect on symptoms WS WS WS WS




ANS: B WS




Rationale: Drugs that produce systemic effects are taken into the body, circulated through the bloodstrea
WS WS WS WS WS WS WS WS WS WS WS WS WS WS




m to their sites of action in various body tissues, and eventually eliminated from the body. Curative age
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




nts are given to cure a disease process. In this case, paroxetine hydrochloride will control the symptoms
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




but not cure the disorder. Drugs with local effects, such as sunscreen and local anesthetics, act
WS WS WS WS WS WS WS WS WS WS WS WS WS WS WS




4|P a g e
WS WS WS WS WS